Aberrant activation of the NLRP3 inflammasome contributes to the progression of many chronic diseases, including gout, Alzheimer’s disease, type II diabetes, atherosclerosis, and cancer1, 18. Here, NLRP3 is linked to early-onset autosomal dominant Alzheimer disease.